Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Non-Current Liabilities (2016 - 2026)

Cumberland Pharmaceuticals' Total Non-Current Liabilities history spans 16 years, with the latest figure at $46.5 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 0.6% to $46.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.5 million, a 0.6% decrease, with the full-year FY2025 number at $46.5 million, down 0.6% from a year prior.
  • Total Non-Current Liabilities hit $46.5 million in Q4 2025 for Cumberland Pharmaceuticals, up from $34.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for CPIX hit a ceiling of $49.4 million in Q4 2022 and a floor of $33.2 million in Q2 2021.
  • Historically, Total Non-Current Liabilities has averaged $42.0 million across 5 years, with a median of $45.1 million in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 43.64% in 2022 and later dropped 26.16% in 2025.
  • Tracing CPIX's Total Non-Current Liabilities over 5 years: stood at $34.4 million in 2021, then surged by 43.64% to $49.4 million in 2022, then decreased by 6.69% to $46.1 million in 2023, then increased by 1.47% to $46.7 million in 2024, then fell by 0.6% to $46.5 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CPIX at $46.5 million in Q4 2025, $34.1 million in Q3 2025, and $33.9 million in Q2 2025.